메뉴 건너뛰기




Volumn 72, Issue 5, 2015, Pages 514-515

Measuring the effects of treatment with antipsychotics [4]

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; PLACEBO;

EID: 84929379820     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2014.3134     Document Type: Letter
Times cited : (1)

References (7)
  • 2
    • 84887478908 scopus 로고    scopus 로고
    • Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010
    • Agid O, Siu CO, Potkin SG, et al. Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010. Am J Psychiatry. 2013;170(11):1335-1344.
    • (2013) Am J Psychiatry , vol.170 , Issue.11 , pp. 1335-1344
    • Agid, O.1    Siu, C.O.2    Potkin, S.G.3
  • 3
    • 84884161208 scopus 로고    scopus 로고
    • Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis
    • Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951-962.
    • (2013) Lancet , vol.382 , Issue.9896 , pp. 951-962
    • Leucht, S.1    Cipriani, A.2    Spineli, L.3
  • 4
    • 0031693994 scopus 로고    scopus 로고
    • An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials
    • Schmid CH, Lau J, McIntosh MW, Cappelleri JC. An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials. Stat Med. 1998;17(17):1923-1942.
    • (1998) Stat Med , vol.17 , Issue.17 , pp. 1923-1942
    • Schmid, C.H.1    Lau, J.2    McIntosh, M.W.3    Cappelleri, J.C.4
  • 6
    • 7844224760 scopus 로고    scopus 로고
    • Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 4-week placebo-controlled trial
    • Keck P Jr, Buffenstein A, Ferguson J, et al. Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial. Psychopharmacology (Berl). 1998;140(2):173-184.
    • (1998) Psychopharmacology (Berl) , vol.140 , Issue.2 , pp. 173-184
    • Keck, P.1    Buffenstein, A.2    Ferguson, J.3
  • 7
    • 0028342655 scopus 로고
    • Risperidone in the treatment of schizophrenia
    • Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry. 1994;151(6):825-835.
    • (1994) Am J Psychiatry , vol.151 , Issue.6 , pp. 825-835
    • Marder, S.R.1    Meibach, R.C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.